Your browser doesn't support javascript.
loading
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial.
Ballantyne, Christie M; Ditmarsch, Marc; Kastelein, John Jp; Nelson, Adam J; Kling, Douglas; Hsieh, Andrew; Curcio, Danielle L; Maki, Kevin C; Davidson, Michael H; Nicholls, Stephen J.
Afiliación
  • Ballantyne CM; Department of Medicine, Baylor College of Medicine, Houston, Texas, United States. Electronic address: cmb@bcm.edu.
  • Ditmarsch M; New Amsterdam Pharma B.V., Naarden, Netherlands.
  • Kastelein JJ; New Amsterdam Pharma B.V., Naarden, Netherlands; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • Nelson AJ; Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia.
  • Kling D; New Amsterdam Pharma B.V., Naarden, Netherlands.
  • Hsieh A; New Amsterdam Pharma B.V., Naarden, Netherlands.
  • Curcio DL; New Amsterdam Pharma B.V., Naarden, Netherlands.
  • Maki KC; Midwest Biomedical Research, Addison, Illinois, United States; Indiana University School of Public Health, Bloomington, Indiana, United States.
  • Davidson MH; New Amsterdam Pharma B.V., Naarden, Netherlands; The University of Chicago Pritzker School of Medicine, Chicago, Illinois, United States.
  • Nicholls SJ; Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia.
J Clin Lipidol ; 17(4): 491-503, 2023.
Article en En | MEDLINE | ID: mdl-37277261
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Anticolesterolemiantes Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Lipidol Asunto de la revista: BIOQUIMICA / METABOLISMO Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Anticolesterolemiantes Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Lipidol Asunto de la revista: BIOQUIMICA / METABOLISMO Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos